Comment on "Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study."

对“将 brentuximab vedotin 与地塞米松、大剂量阿糖胞苷和顺铂联合用于复发或难治性霍奇金淋巴瘤的挽救治疗：II 期 HOVON/LLPC 移植 BRaVE 研究”进行评论。